Current
Recommendations of the Advisory Committee on Immunization Practices for Use of a Hepatitis B Vaccine with a Novel Adjuvant
MMWR, April 20, 2018; 67 (15): 455-458
Current
Recommendations of the Advisory Committee on Immunization Practices for Use of Herpes Zoster Vaccines
MMWR, January 26, 2018; 67(3); 103–108
Current
Recommendations of the Advisory Committee on Immunization Practices for Use of a Third Dose of Mumps Virus-Containing Vaccine in Persons at Increased Risk for Mumps During an Outbreak
MMWR, January 12, 2018; 67(1); 33–37
Current
Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices
MMWR, January 12, 2018; 67 (1); 1–31
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2017–18 Influenza Season
MMWR, August 25, 2017, 66(2); 1–20
Current
Prevention of Varicella
MMWR, June 22, 2007; 56(RR-4):1-40
Archived
Updated Recommendations for Use of MenB-FHbp Serogroup B (Trumenba) Meningococcal Vaccine
MMWR, May 19, 2017; 66(19); 509-513
Current
Recommendations of the Advisory Committee on Immunization Practices for Use of Cholera Vaccine
MMWR May 12, 2017, 66(18);482–485
Current
Guidance for Assessment of Poliovirus Vaccination Status and Vaccination of Children Who Have Received Poliovirus Vaccine Outside the United States
MMWR, January 13, 2017; 66(01); 23–25
-
HPV (Human Papillomavirus)
Current
Use of a 2-Dose Schedule for Human Papillomavirus Vaccination: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR, December 16, 2016; 65(49);1405-8
Archived
Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons – Advisory Committee on Immunization Practices (ACIP), 2016
MMWR, November 4, 2016, Vol. 65(43);1189–1194
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2016–17 Influenza Season
MMWR, August 26, 2016, Vol. 65(5):1-54
Current
Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses—Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
MMWR, March 18, 2016, Vol. 65(10):257-262
Archived
Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015
MMWR, October 23, 2015; 64(41)1171–1176
Archived
Update: Shortened Interval for Postvaccination Serologic Testing of Infants Born to Hepatitis B-Infected Mothers
MMWR, October 9, 2015; 64(39):1118-20
Current
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, September 4, 2015; 64(34):944-947
Archived
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2015–16 Influenza Season
MMWR, August 7, 2015; 64(30):818-825
Current
Yellow Fever Vaccine Booster Doses: Recommendations of the Advisory Committee on Immunization Practices, 2015
MMWR, June 19, 2015; 64(23);647-650
Archived
Use of Serogroup B Meningococcal Vaccines in Persons Aged >10 Years at Increased Risk for Serogroup B Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices, 2015
MMWR, June 12, 2015; 64(22);608-612
Current
Updated Recommendations for the Use of Typhoid Vaccine — Advisory Committee on Immunization Practices, United States, 2015
MMWR, March 27, 2015;64(11):305–308,
-
HPV (Human Papillomavirus)
Current
Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices
MMWR, March 27, 2015; 64(11):300-304
Current
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged >65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, September 19, 2014; 63(37):822-825
-
HPV (Human Papillomavirus)
Current
Human Papillomavirus Vaccination: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, August 29, 2014; 63(RR-5):1-30
Archived
Update on Recommendations for Use of Herpes Zoster Vaccine
MMWR, August 22, 2014; 63(33):729-731
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2014–2015
MMWR, August 15, 2014; 63(327):691–697
Archived
Use of MenACWY-CRM Vaccine in Children Aged 2 Through 23 Months at Increased Risk for Meningococcal Disease
MMWR, June 20, 2014; 63(24):527-530
-
Hib (Haemophilus Influenzae Type B)
Current
Prevention and Control of Haemophilus influenzae Type b Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP) Recommendations and Reports
MMWR, February 28, 2014; 63(RR01):1-14
Archived
CDC Guidance for Evaluating Health-Care Personnel for Hepatitis B Virus Protection and for Administering Postexposure Management – Recommendations and Reports
MMWR, December 20, 2013; 62(rr10);1-19 (Not an ACIP statement but an important document from CDC.)
-
Japanese Encephalitis (JE)
Archived
Use of Japanese Encephalitis Vaccine in Children: Recommendations of the Advisory Committee on Immunization Practices, 2013
MMWR, November 15, 2013; 62(45):898-900
Archived
Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices — United States, 2013–2014
MMWR, September 20, 2013; 62(RR–7):1-48
Current
Updated Recommendations for Use of VariZIG -- United States, 2013
MMWR, July 19, 2013; 62(28):574-6
Current
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 28, 2013; 62(25):521-524
Current
Prevention of Measles, Rubella, Congenital Rubella Syndrome, and Mumps, 2013 -- Summary Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, June 14, 2013; 62(RR04):1-34
Archived
Prevention and Control of Influenza with Vaccines: Interim Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2013 Weekly
MMWR, May 10, 2013; 62(18):356
Archived
Prevention and Control of Meningococcal Disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, March 22, 2013; 62(RR02):1-22
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine (Tdap) in Pregnant Women - Advisory Committee on Immunization Practices (ACIP)
MMWR, February 22, 2013;62(07):131-5
Archived
Infant Meningococcal Vaccination: Advisory Committee on Immunization Practices (ACIP) Recommendations and Rationale
MMWR, January 25, 2013; 62(3):52-4
Current
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, October 12, 2012; 61(40):816-9
Archived
Prevention and Control of Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP)—United States, 2012–13 Influenza Season
MMWR, August 18, 2012;61(32);613-8
Archived
Updated CDC Recommendations for the Management of Hepatitis B Virus–Infected Health-Care Providers and Students
MMWR, July 6, 2012; 61(RR03):1-12
Archived
Licensure of 13-Valent Pneumococcal Conjugate Vaccine for Adults Aged 50 Years and Older
MMWR, June 1, 2012; 61(21):394-5
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis (Tdap) Vaccine in Adults Aged 65 Years and Older — Advisory Committee on Immunization Practices (ACIP), 2012
MMWR, June 29, 2012; 61(25):468-70
Archived
Use of Hepatitis B Vaccination for Adults with Diabetes Mellitus: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, December 23, 2011; 60(50):1709-11
-
HPV (Human Papillomavirus)
Archived
Recommendations on the Use of Quadrivalent Human Papillomavirus Vaccine in Males — Advisory Committee on Immunization Practices (ACIP), 2011
MMWR, December 23, 2011; 60(50):1705-8
Current
History of Intussusception as a Contraindication for Rotavirus Vaccination
MMWR, October 21, 2011;60(41):1427-1427
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine (Tdap) in Pregnant Women and Persons Who Have or Anticipate Having Close Contact with an Infant Aged <12 Months -- Advisory Committee on Immunization Practices (ACIP), 2011
MMWR, October 21, 2011; 60(41):1424-1426
Archived
Recommendation of the Advisory Committee on Immunization Practices (ACIP) for Use of Quadrivalent Meningococcal Conjugate Vaccine (MenACWY-D) Among Children Aged 9 Through 23 Months at Increased Risk for Invasive Meningococcal Disease
MMWR, October 14, 2011; 60(40):1391-2
Archived
Licensure of a Meningococcal Conjugate Vaccine for Children Aged 2 Through 10 Years and Updated Booster Dose Guidance for Adolescents and Other Persons at Increased Risk for Meningococcal Disease — Advisory Committee on Immunization Practices (ACIP), 2011
MMWR, August 5, 2011; 60(30):1018-1019
-
Japanese Encephalitis (JE)
Archived
Recommendations for Use of a Booster Dose of Inactivated Vero Cell Culture-Derived Japanese Encephalitis Vaccine -- Advisory Committee on Immunization Practices, 2011
MMWR, May 27, 2011; 60(20):661-3
-
Japanese Encephalitis (JE)
Archived
Update on Japanese Encephalitis Vaccine for Children
MMWR, May 27, 2011; 60(20):664-5
Archived
Updated Recommendations for Use of Meningococcal Conjugate Vaccines--Advisory Committee on Immunization Practices (ACIP), 2010
MMWR, January 28, 2011; 60(03):72-76
Archived
Antiviral Agents for the Treatment and Chemoprophylaxis of Influenza
MMWR, January 21, 2011; 60(RR01):1-24
-
Diphtheria
-
Pertussis
-
Tetanus
Archived
Updated Recommendations for Use of Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis (Tdap) Vaccine from the Advisory Committee on Immunization Practices, 2010
MMWR, January 14, 2011; 60(01):13-15
-
Hepatitis A
-
Hepatitis B
-
HPV (Human Papillomavirus)
Archived
Sexually Transmitted Diseases Treatment Guidelines, 2010
MMWR, December 17, 2010; 59(RR12):1-110
Current
Prevention of Pneumococcal Disease Among Infants and Children--Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine
MMWR, December 10, 2010; 59(RR11):1-18
Current
Updated ACIP Recommendations: Prevention of Invasive Pneumococcal Disease Among Adults Using the 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23)
MMWR, September 3, 2010; 59(34):1102-6
Current
Yellow Fever Vaccine: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR, July 30, 2010; 59(RR07):1-27
Archived
Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009
MMWR, July 23, 2010; 59(rr06):1-36
Current
Severe Combined Immunodeficiency as a Contraindication for Administration of Rotavirus Vaccine
MMWR June 11, 2010;59(22):687-688
-
HPV (Human Papillomavirus)
Archived
FDA Licensure of Bivalent Human Papillomavirus Vaccine (HPV2, Cervarix) for Use in Females and Updated HPV Vaccination Recommendations from the Advisory Committee on Immunization Practices (ACIP)
MMWR, May 28, 2010; 59(20):626-629
-
HPV (Human Papillomavirus)
Archived
FDA Licensure of Quadrivalent Human Papillomavirus Vaccine (HPV4, Gardasil) for Use in Males and Guidance from the Advisory Committee on Immunization Practices (ACIP) Weekly
MMWR, May 28, 2010; 59(20):630-632
-
Measles
-
Mumps
-
Rubella
-
Varicella (Chickenpox)
Current
Use of Combination Measles, Mumps, Rubella, and Varicella Vaccine--Recommendations of the Advisory Committee on Immunization Practices
MMWR, May 7, 2010; 59(RR--3):1 - 16
Archived
Licensure of a High-Dose Inactivated Influenza Vaccine for Persons Aged >=65 Years (Fluzone High-Dose) and Guidance for Use--United States, 2010
MMWR, April 30, 2010; 59(16):485-486
Current
Use of a Reduced (4-Dose) Vaccine Schedule for Postexposure Prophylaxis to Prevent Human Rabies
MMWR, March 19, 2010; 59(02):1-9
Archived
Licensure of a Meningococcal Conjugate Vaccine (Menveo) and Guidance for Use--Advisory Committee on Immunization Practices (ACIP), 2010
MMWR, March 12, 2010; 59(09):273
